Joincare(SH:600380) Zheng Quan Zhi Xing·2025-08-22 16:48Core Viewpoint - The board of directors of Health元药业集团 has convened to approve several key reports and proposals during its twelfth meeting of the ninth session, emphasizing the company's commitment to transparency and governance [1][2][3]. Group 1: Meeting Details - The meeting was held on August 22, 2025, in Shenzhen, with all nine directors present, along with members of the supervisory board and senior management [1]. - The meeting was chaired by Chairman Zhu Baoguo and conducted via a combination of in-person and video conferencing [1]. Group 2: Resolutions Passed - The board approved the 2025 semi-annual report and its summary, which will be published on August 23, 2025, across various platforms [1]. - The board also approved the special report on the storage and actual use of raised funds for the first half of 2025, with unanimous support [2]. - A mid-year evaluation report on the "Quality Improvement and Efficiency Enhancement Action Plan" was also approved, reflecting the company's ongoing strategic initiatives [2]. - The board passed a resolution to amend certain provisions of the company's sustainable development system, which has been reviewed by the sustainability committee [3]. - Additionally, the board approved amendments to the anti-corruption and anti-commercial bribery policy, also reviewed by the sustainability committee [3].